-
Je něco špatně v tomto záznamu ?
Squamous cell carcinoma antigen as a marker of sinonasal inverted papilloma
P. Matoušek, K. Zeleník, K. Safarčík, L. Cábalová, P. Komínek,
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, práce podpořená grantem
Odkazy
PubMed
23778724
DOI
10.1007/s00405-013-2604-z
Knihovny.cz E-zdroje
- MeSH
- antigeny nádorové krev MeSH
- dospělí MeSH
- invertovaný papilom krev chirurgie MeSH
- kohortové studie MeSH
- lidé středního věku MeSH
- lidé MeSH
- lokální recidiva nádoru krev MeSH
- longitudinální studie MeSH
- nádorové biomarkery krev MeSH
- nádory nosu krev chirurgie MeSH
- nádory vedlejších dutin nosních krev chirurgie MeSH
- progrese nemoci MeSH
- prospektivní studie MeSH
- senioři MeSH
- serpiny krev MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- senioři MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
This prospective study aimed to evaluate the usefulness of squamous cell carcinoma antigen (SCCA) as a clinical marker of sinonasal inverted papilloma (IP). The potential benefit of SCCA in the diagnosis of unilateral nasal pathology and as a marker of hidden recurrence was evaluated as well. Blood samples from patients with sinonasal IP were examined to determine serum SCCA levels before surgery, the day after surgery, and every 6 months during follow-up. Preoperative and postoperative levels of SCCA were compared. Twenty consecutive patients with histologically confirmed IP were included in the study, conducted between 2000 and 2011. The mean age of the patients was 54.2 years (range 35-72). The mean serum SCCA level before surgery was 3.885 μg/l (range 0.7-7.6). A decrease of the SCCA level to 0.885 μg/l (range 0.1-1.9) was observed on the 1 day after a radical surgical procedure. A statistically significant difference between the preoperative and postoperative levels was observed (P < 0.001). Elevated levels of SCCA during long-term follow-up were observed in three patients. All of them had a recurrence of IP. We conclude that the serum level of SCCA is a useful clinical marker of the presence of sinonasal IP. The level of SCC antigen was significantly lower in patients after IP was completely removed. According to our results, SCCA level also appears to be useful for long-term follow-up (hidden recurrence diagnosis).
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15008605
- 003
- CZ-PrNML
- 005
- 20150324112625.0
- 007
- ta
- 008
- 150306s2014 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00405-013-2604-z $2 doi
- 035 __
- $a (PubMed)23778724
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Matoušek, Petr $u Department of Otorhinolaryngology, University Hospital Ostrava, 17. Listopadu Street 1790, 708 52, Ostrava-Poruba, Czech Republic.
- 245 10
- $a Squamous cell carcinoma antigen as a marker of sinonasal inverted papilloma / $c P. Matoušek, K. Zeleník, K. Safarčík, L. Cábalová, P. Komínek,
- 520 9_
- $a This prospective study aimed to evaluate the usefulness of squamous cell carcinoma antigen (SCCA) as a clinical marker of sinonasal inverted papilloma (IP). The potential benefit of SCCA in the diagnosis of unilateral nasal pathology and as a marker of hidden recurrence was evaluated as well. Blood samples from patients with sinonasal IP were examined to determine serum SCCA levels before surgery, the day after surgery, and every 6 months during follow-up. Preoperative and postoperative levels of SCCA were compared. Twenty consecutive patients with histologically confirmed IP were included in the study, conducted between 2000 and 2011. The mean age of the patients was 54.2 years (range 35-72). The mean serum SCCA level before surgery was 3.885 μg/l (range 0.7-7.6). A decrease of the SCCA level to 0.885 μg/l (range 0.1-1.9) was observed on the 1 day after a radical surgical procedure. A statistically significant difference between the preoperative and postoperative levels was observed (P < 0.001). Elevated levels of SCCA during long-term follow-up were observed in three patients. All of them had a recurrence of IP. We conclude that the serum level of SCCA is a useful clinical marker of the presence of sinonasal IP. The level of SCC antigen was significantly lower in patients after IP was completely removed. According to our results, SCCA level also appears to be useful for long-term follow-up (hidden recurrence diagnosis).
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a antigeny nádorové $x krev $7 D000951
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a longitudinální studie $7 D008137
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a lokální recidiva nádoru $x krev $7 D009364
- 650 _2
- $a nádory nosu $x krev $x chirurgie $7 D009669
- 650 _2
- $a invertovaný papilom $x krev $x chirurgie $7 D018308
- 650 _2
- $a nádory vedlejších dutin nosních $x krev $x chirurgie $7 D010255
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a serpiny $x krev $7 D015843
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a nádorové biomarkery $x krev $7 D014408
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Zeleník, Karol
- 700 1_
- $a Safarčík, Kristián
- 700 1_
- $a Cábalová, Lenka
- 700 1_
- $a Komínek, Pavel
- 773 0_
- $w MED00009617 $t European archives of oto-rhino-laryngology official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery $x 1434-4726 $g Roč. 271, č. 3 (2014), s. 535-8
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23778724 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150306 $b ABA008
- 991 __
- $a 20150324112913 $b ABA008
- 999 __
- $a ok $b bmc $g 1065878 $s 891405
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 271 $c 3 $d 535-8 $i 1434-4726 $m European archives of oto-rhino-laryngology $n Eur Arch Otorhinolaryngol $x MED00009617
- LZP __
- $a Pubmed-20150306